Completed Projects

Basic Science Studies

Funder – American Lung Association

Title – Role of PDLIM5 in the Pathogenesis of Pulmonary Hypertension

Date of Archival – 3/1/2019

Funder – Chancellor’s Proof of Concept Grant

Title – Sphingolipid signaling in Bronchopulmonary dysplasia

Date of Archival – 3/1/2019

Funder – NIH: NHLBI

Title – Role of Nrf2 in Alveolar Epithelial Cell Regeneration During Lung Repair

Date of Archival – 3/1/2019

Funder – Acetylon Pharmaceuticals Inc

Title – Effective HUDEP Inhibitors on HbF

Date of Archival – 1/3/2019

Clinical & Pharmaceutical Studies

Title – A Retrospective Analysis of Extubation Profiles in Very Low Birth Weight Infants and Correlation with Neonatal Morbidities

Title – A Retrospective chart review to assess risk factors leading to hospital re-admissions for neonatal hyperbilirubinemia.

Title – A Retrospective Study of Correlation of Pre-natal and Post-natal Risk Factors and Outcomes in Late Preterm Infants

Title – Medical Neglect in T1DM. What are the criteria?

Title  – ANSWER Registry (Concluded in 2017)

    • Description – An Observational Study Assessing Treatment Outcomes and Safety for Children and Adults who are Prescribed Norditropin.

Title – Carbohydrates Recognition and Counting Ability in Pediatric Resident before and after Nutritional Education Intervention (Completed: November, 2016)

Title – Relationship between performances on 2 nutrition based questionnaires and Diabetes control, diabetes education and length of diagnosis (Completed: February, 2019)

Title – Type 1 Diabetes TrialNet Study

  • Sponsor – University of South Florida (Prime sponsor: NIH)
  • Description –
  • The Type 1 Diabetes TrialNet is an international diabetes trial network of cooperative clinical research groups to create a stable, high quality infrastructure needed for the conduct of effective and efficient clinical trials in diabetes.

Title – MMSAP T Adeniyi -Life Beyond Sickle Cell Disease Post-Transplant (Concluded in 2016)

  • Sponsor – American Society of Hematology

Title – An Open-Label Study to Evaluate the Safety And Pharmacokinetics Of Pf-06412528 in Children 7-17 Years for the Treatment of Moderate-to-Severe Pain B4541006 ( Concluded in 2019)  Link to Clinical 

  • Sponsor – Pfizer Inc.

Title –  An Open-label, Multicenter Study for the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for (Concluded in 2016) Link to Clinical

  • Sponsor – Purdue Pharma LP

Title –  Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) (Concluded in 2016) Link to Clinical

  • Sponsor – Mast Therapeutics

Title –  Multicenter, Open-label, Randomized, Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-Ranging Phase II Study of Ticagrelor Followed by a Single-Blind, Randomized, Parallel-Group, Placebo-Controlled (Concluded in 2017)

  • Sponsor – Icon Clinical Research Inc. 

Title – Three Month Prospective Open Label Study of Therapy With Fragmin (Dalteparin Sodium Injection) in Children With or Without Malignancies and Venous Thromboembolism- Pfister Protocol# A6301094 (Concluded as of 2019) Link to Clinical 

  • Sponsor – Inventiv

Title – Arginine Therapy for the Treatment of Pain in Children with Sickle Cell Disease (Concluded in 2016) Link to Clinical

  • Sponsor – Emory University 

Title – The Coleman Supportive Oncology Collaborative for Children with Cancer, Cycle 2

  • Sponsor – Coleman Foundation

Dr. Choi is no longer at UIC. 

Title –  Evaluation of Atopy as a Pre-Existing Risk Factor for Hypersensitivity to Asparaginase in Patients with Pediatric Acute Lymphoblastic Leukemia

Clinical and Community Research and Programs

Title – Work related stress and patient safety in UIC hospital NICU

Date of Archival  – 3/1/2019

Title – Inter-professional Study of Oral Health in Primary Care: Common Risk Factor Study (Concluded in 2015)

  • Sponsor – American Academy of Pediatrics

Title – The Revision of a Pediatric Joint Fellowship Curriculum

Date of Archival  – 3/1/2019

Title – Parent and Guardian Knowledge of Hematopoietic Stem Cell Transplantation as a Treatment for Sickle Cell Disease

  • Sponsor – Cleveland Clinic Foundation

Title – BEATS Chicago Edition- Hip-Hop Music Therapy for Kids with Sickle Cell Disease

  • Sponsor –  Joy in Childhood Foundation

Title – PINPOINT: Gaming technology to engage adolescent sickle cell patients in precision pain management

  • Sponsor – Hilton Publishing
  • Title – 

Funder – UCLA

Title – Healthy Minds, Healthy Children, Healthy Chicago (H3)

Date of Archival – 1/4/2019

Title –  Refusal of intramuscular vitamin K prophylaxis in newborns

Date of Archival – 11/2/2018

Title – Pulmonary Hypertension increases length of NICU stay, mortality and social worker use

Date of Archival – 1/3/2019

Title – Developing a Tool to Evaluate Patient-Provider Communication & Patient Satisfaction in Adult Asthma Management

Date of Archival – 2/12/2018

Title – Connecting Early Childhood Education and Medical Homes

Date of Archival – 3/1/2019

Title – African American Parent Management of Children with ADHD Focus Group Study

Date of Archival – 12/17/2017

Funder – NIH: NIDHC
Title – Promoting Early Child Development in Primary Care in Low Income Families

Date of Archival – 3/1/2019

  • Project – Dreamfields 50 States/ 50 Plates 2013 Health Initiative Individual Award
    • Sponsor – M&P Food Communications
  • Project – Diabetes Care in Schools: An Educational Program for School Nurses and Delegated Care Aids
    • Sponsor – Medtronic Inc.

Title – Opportunity Costs of Sickle Cell Disease

Date of Archival – 7/29/2018

Funder – NIH

Title – Primary Care Internet-based Depression Prevention For Adolescents (Catch-It)

Date of Arrival – 9/19/2015

Partner Programs

Funder – Novartis Pharmaceuticals Corp

Title – A Randomized, Controlled Study Evaluating the Efficacy and Safety of Ranibizumab Compared with Laser Therapy for the Treatment of Infants Born Prematurely with Retinopathy of Prematurity

Date of Archival – 8/31/2018

Funder – Univ of Pittsburgh

Title – A Phase IIb Randomized, Double-Blind, Placebo Controlled Multi-Center Study Assess the Safety, Tolerability and Efficacy of Riociguat in Patients with SCD (STERIO-SCD)

Date of Archival – 9/30/2018

UIC Faculty – Dr. Lewis Hu

Funder – inVentiv

Title –  A Phase 1B, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04447943, Co-Aministered with and Wwithout Hydroxyurea

Date of Archival – 3/4/2018

UIC Faculty – Dr. Lewis Hu

Funder – Chicago Community Trust

Title – Chicago Area Patient Centered Outcomes Research Network (CAPriCORN)

Date of Archival – 8/31/2018

UIC Faculty – Dr. Marian Fitzgibbon

Funder – NIH

Title –  Vascular- Targeted Genomic and Genetic Strategies for Acute Chest Syndrome.

Date of Archival – 1/31/2018

UIC Faculty – Dr. Zhang

Funder – NIH

Title – Acquisition of Hyperpolarized Gas System for Lung MR Imaging

Date of Archival – 1/31/2018

UIC Faculty – Dr. Sekhar Reddy

Funder – NIH: NCI

Title – Environmental Attributes and Weight Control: Study of Over 1.3 Million Veterans

Date of Archival – 6/30/2018

UIC Faculty – Dr. Marian Fitzgibbon

Title –Comprehensive sickle cell clinical care program – FY18

Date of Archival – 6/30/2018

UIC Faculty – Dr. Lewis Hu

Title –Comparative effectiveness of fit and strong vs fit and strong plus

Date of Archival – 2/28/2018

UIC Faculty – Dr. Marian Fitzgibbon

Title – Chicago Community Trust – Bariatrics

Date of Archival – 1/31/2018

UIC Faculty – Dr. Marian Fitzgibbon

Title – Chicago Community Trust – PCORNET obesity observational study

Date of Archival – 1/31/2018

UIC Faculty – Dr. Marian Fitzgibbon

Title – Bring care to patients: a patient-centered nedical home for kidney disease

Date of Archival – 11/30/2017

UIC Faculty – Dr. Marian Fitzgibbon